Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD

28.03  -0.3 (-1.06%)

After market: 28.03 0 (0%)

Fundamental Rating

4

Overall QDEL gets a fundamental rating of 4 out of 10. We evaluated QDEL against 187 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of QDEL while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on QDEL.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

QDEL had positive earnings in the past year.
In the past year QDEL had a positive cash flow from operations.
In multiple years QDEL reported negative net income over the last 5 years.
In the past 5 years QDEL always reported a positive cash flow from operatings.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

The Return On Assets of QDEL (-5.55%) is better than 66.31% of its industry peers.
Looking at the Return On Equity, with a value of -11.97%, QDEL is in the better half of the industry, outperforming 65.78% of the companies in the same industry.
QDEL's Return On Invested Capital of 1.25% is fine compared to the rest of the industry. QDEL outperforms 68.45% of its industry peers.
QDEL had an Average Return On Invested Capital over the past 3 years of 4.37%. This is below the industry average of 7.89%.
Industry RankSector Rank
ROA -5.55%
ROE -11.97%
ROIC 1.25%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

With a decent Operating Margin value of 3.11%, QDEL is doing good in the industry, outperforming 68.45% of the companies in the same industry.
In the last couple of years the Operating Margin of QDEL has declined.
With a Gross Margin value of 46.94%, QDEL perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 3.11%
PM (TTM) N/A
GM 46.94%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
Compared to 1 year ago, QDEL has more shares outstanding
Compared to 5 years ago, QDEL has more shares outstanding
QDEL has a worse debt/assets ratio than last year.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

QDEL has an Altman-Z score of 0.87. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.87, QDEL is in line with its industry, outperforming 48.13% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that QDEL is somewhat dependend on debt financing.
QDEL has a Debt to Equity ratio of 0.70. This is in the lower half of the industry: QDEL underperforms 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.14
WACC8.85%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.20 indicates that QDEL should not have too much problems paying its short term obligations.
The Current ratio of QDEL (1.20) is worse than 82.89% of its industry peers.
QDEL has a Quick Ratio of 1.20. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QDEL (0.66) is worse than 91.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.66
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

QDEL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.38%.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
Looking at the last year, QDEL shows a decrease in Revenue. The Revenue has decreased by -3.42% in the last year.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%

3.2 Future

Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.08% on average per year.
QDEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.31% yearly.
EPS Next Y32.45%
EPS Next 2Y33.47%
EPS Next 3Y32.67%
EPS Next 5Y25.08%
Revenue Next Year-2.19%
Revenue Next 2Y1%
Revenue Next 3Y2.29%
Revenue Next 5Y2.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.04, QDEL is valued correctly.
QDEL's Price/Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 87.17% of the companies in the same industry.
QDEL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.34.
A Price/Forward Earnings ratio of 8.50 indicates a reasonable valuation of QDEL.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 94.12% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (21.03), we can say QDEL is valued rather cheaply.
Industry RankSector Rank
PE 13.04
Fwd PE 8.5
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaply inside the industry as 94.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.03
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 32.67% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y32.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUIDELORTHO CORP

NASDAQ:QDEL (6/20/2025, 8:00:02 PM)

After market: 28.03 0 (0%)

28.03

-0.3 (-1.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners112.09%
Inst Owner Change3.24%
Ins Owners0.54%
Ins Owner Change1.91%
Market Cap1.90B
Analysts78.67
Price Target51.29 (82.98%)
Short Float %5.83%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.18%
Min EPS beat(2)4.59%
Max EPS beat(2)23.78%
EPS beat(4)4
Avg EPS beat(4)65.27%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)33.31%
EPS beat(12)9
Avg EPS beat(12)36.06%
EPS beat(16)12
Avg EPS beat(16)30.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.75%
Revenue beat(4)2
Avg Revenue beat(4)2.64%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)11.02%
Revenue beat(8)5
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)1.78%
Revenue beat(16)11
Avg Revenue beat(16)4.61%
PT rev (1m)-5.63%
PT rev (3m)-5.88%
EPS NQ rev (1m)-6.81%
EPS NQ rev (3m)-96.12%
EPS NY rev (1m)1.06%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-3.01%
Valuation
Industry RankSector Rank
PE 13.04
Fwd PE 8.5
P/S 0.69
P/FCF N/A
P/OCF 12.7
P/B 0.63
P/tB N/A
EV/EBITDA 8.03
EPS(TTM)2.15
EY7.67%
EPS(NY)3.3
Fwd EY11.76%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)2.21
OCFY7.88%
SpS40.88
BVpS44.32
TBVpS-5.49
PEG (NY)0.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.55%
ROE -11.97%
ROCE 1.59%
ROIC 1.25%
ROICexc 1.28%
ROICexgc 3.54%
OM 3.11%
PM (TTM) N/A
GM 46.94%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 3.96
Cap/Depr 41.56%
Cap/Sales 6.7%
Interest Coverage 250
Cash Conversion 28.09%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 0.66
Altman-Z 0.87
F-Score5
WACC8.85%
ROIC/WACC0.14
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
EPS Next Y32.45%
EPS Next 2Y33.47%
EPS Next 3Y32.67%
EPS Next 5Y25.08%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
Revenue Next Year-2.19%
Revenue Next 2Y1%
Revenue Next 3Y2.29%
Revenue Next 5Y2.31%
EBIT growth 1Y-34.7%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year933.72%
EBIT Next 3Y133.74%
EBIT Next 5Y88.95%
FCF growth 1Y-109.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.95%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%